Qiagen N.V. (QGEN) Stock

Qiagen N.V. is a global leader in providing end-to-end solutions that unlock molecular insights from biological samples. Founded in 1986 and headquartered in Venlo, the Netherlands, Qiagen specializes in sample to insight technologies that encompass nucleic acid purification, sample processing automation, and advanced molecular analysis tools. The company offers a comprehensive range of products including nucleic acid stabilization kits, purification technologies utilizing silica membranes and magnetic beads, and automated instruments for genotyping, gene expression analysis, viral and bacterial detection, and more.

Qiagen's innovative solutions cater to diverse sectors including molecular diagnostics, academic research, pharmaceutical development, and applied testing. Beyond consumables and instruments, Qiagen provides specialized assays for infectious diseases, prenatal screening, and genomic variant analysis such as mutations and fusions. The company also offers custom NGS gene panels, library preparation kits, and bioinformatics solutions to support genomic research and personalized medicine initiatives.

With strategic partnerships with Sysmex Corporation and OncXerna Therapeutics, and collaborations with Mirati and other industry leaders, Qiagen continues to expand its capabilities in molecular biology and diagnostics. Committed to driving advancements in healthcare and life sciences, Qiagen remains at the forefront of transforming biological materials into actionable molecular insights worldwide.